Balance Sheet

Accounts Payables Accumulated Expenses Assets Buildings Cash & Current Investments Cash & Equivalents Common Equity Curent Deferred Tax Liability Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Leases Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Prepaid Assets Property, Plant & Equipment (Net)Raw Materials Receivables Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Daily Values

Growth Metrics

Others

Bio-Rad Laboratories (BIO) Goodwill (2016 - 2025)

Bio-Rad Laboratories (BIO) has disclosed Goodwill for 14 consecutive years, with $160.5 million as the latest value for Q2 2025.

On a quarterly basis, Goodwill changed N/A to $160.5 million in Q2 2025 year-over-year; TTM through Jun 2025 was $160.5 million, a N/A change, with the full-year FY2023 number at $413.6 million, changed N/A from a year prior.
Goodwill was $160.5 million for Q2 2025 at Bio-Rad Laboratories, down from $413.6 million in the prior quarter.
In the past five years, Goodwill ranged from a high of $413.6 million in Q4 2023 to a low of $160.5 million in Q2 2025.
A 3-year average of $307.1 million and a median of $347.3 million in 2021 define the central range for Goodwill.